线,palbociclib,

Paul Cottu1, Yann Kieffer2, Jerome Lemonnier3

  • 1Department of Medical Oncology, Institut Curie, Paris, France; Université Paris Cité, Paris, France; French Breast Cancer InterGroup UCBG, Research and Development Department, Unicancer, Paris, France; IHU Institute of Women's Cancer, Institut Curie, Paris, France.

Cell reports. Medicine
|January 10, 2026
PubMed
概括

新辅助剂莱特醇-帕尔博西克利布 (LP) 和化疗 (CT) 同样降低了高风险光线乳腺癌的增殖和改变了免疫特征. 这些发现支持探索早期乳腺癌治疗的化疗节约选择.